Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1916-07-0Trimethoprim EP Impurity H

● In Stock

Catalogue No.:	VL1640001
CAS No.:	1916-07-0
Mol. Formula:	C11H14O5
Mol. Weight:	226.63 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1916-07-0

Parent drug

Trimethoprim / Trimebutine

IUPAC Name

methyl 3,4,5-trimethoxybenzoate

Pharmacopoeial Synonyms

Trimebutine EP Impurity C

Other Synonyms

Trimethylgallic acid methyl ester; 3,4,5-Trimethoxybenzoic acid methyl ester; Methyl tri-O-methylgallate; Methyl gallate trimethyl ether; Benzoic acid, 3,4,5-trimethoxy-, methyl ester

Smiles

O=C(OC)C1=CC(OC)=C(OC)C(OC)=C1

InChI

InChI=1S/C11H14O5/c1-13-8-5-7(11(12)16-4)6-9(14-2)10(8)15-3/h5-6H,1-4H3

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

Trimethoprim EP Impurity H, also known as Trimebutine EP Impurity C in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Trimethoprim/Trimebutine. Trimethoprim EP Impurity H (CAS No: 1916-07-0) Or methyl 3,4,5-trimethoxybenzoate, it is an impurity of Trimethoprim, It is diaminopyrimidine antibacterial drug, which is used for the treatment of infections due to sensitive organisms, including gastro-enteritis, respiratory tract infections.